A Leader in Asthma Research and Care

National Jewish Health is ranked as the #1 respiratory hospital in the nation by U.S. News & World Report. We are the place in the United States where physicians refer the most difficult cases of asthma.

The institution has pioneered asthma research and treatment since it first emerged as a public health threat in the 1950s. We drew upon our expertise in the treatment of lung conditions to create the nation’s first large inpatient adult asthma service. In 1960, our scientists developed the first clinically useful method of diagnosing asthma.
 
Many of the most effective medications for asthma and allergies, including Advair®, Claritin® and Xolair®, have been introduced to the marketplace as a direct result of the clinical trial work performed at National Jewish Health. Today, we have the largest pulmonology division in the nation and more top-ranked pulmonologists than any other institution.

National Jewish Health physician-scientists are on the cutting edge of asthma research – studying the disease from all angles to improve understanding and discover new treatments for this complex and prevalent disease.